Bioinformatics Startups in Focus as SeqOne Genomics Bags €20M
The French company SeqOne Genomics has raised €20M in a Series A round as growing…
26/01/2022 - 4 minutes
France
French Project to Tackle Antibiotic Resistance with Biotech and Economics
A team of French organizations led by the biotech firm Antabio has launched a €17M…
07/01/2022 - 4 minutes
DNA Manufacturing Startups Net Venture Capital Windfalls
Touchlight Genetics and DNA Script have closed major venture financing rounds in the last month…
28/10/2021 - 6 minutes
Valneva’s Inactivated Covid-19 Vaccine Aces Phase III Trial
Last week, the French vaccine maker Valneva announced promising phase III trial results of its…
26/10/2021 - 5 minutes
Gene-Edited T Cell Therapy Players Battle Safety Doubts
Confidence in gene-edited T cell therapies from donor cells has faltered as Allogene Therapeutics paused…
22/10/2021 - 5 minutes
Chikungunya Vaccine First to Succeed in Phase III Trial
In a significant step in the fight against tropical disease, the mosquito-borne viral disease chikungunya…
19/08/2021 - 3 minutes
Microbiome Medicines Could Power Up CAR-T Cell Therapies
The microbiome could pave new cancer immunotherapy inroads for European biotechs, bolstered by preclinical findings…
28/07/2021 - 5 minutes
Avantium and Carbios Capitalize on Growing Bioplastics Demand
As the EU phases out a wide range of single-use plastics this year, investor interest…
18/05/2021 - 5 minutes
Microbiome Therapies Threatened by Covid-19 Restrictions
Providers of microbiome therapies worldwide have been hit by pandemic restrictions on the harvest of…
01/09/2020 - 5 minutes
Update: DNA Script Raises €80M to Bring Rapid DNA Synthesis to the Lab
Update on 29/07/2020: DNA Script has increased the total raised in its Series B round…
29/07/2020 - 3 minutes
Biological Fungicide Clears Wheat of Rust Disease in European Field Trial
A fungicide derived from amoeba has proven effective at protecting wheat from rust disease and…
27/07/2020 - 2 minutes
Osivax Raises €32M to Develop Universal Coronavirus and Influenza Vaccines
Osivax, a Lyon-based biotechnology company, secured €17.5M from the European Innovation Council and €15.1M from…
08/07/2020 - 3 minutes
